BIOGEN INC. — Investor Relations & Filings
Biogen Inc. is a global biotechnology company focused on discovering, developing, and delivering innovative therapies for people with serious neurological and neurodegenerative diseases. Founded in 1978, the company leverages cutting-edge science to address complex and hard-to-treat conditions. Its core therapeutic areas include multiple sclerosis, Alzheimer's disease, spinal muscular atrophy, and amyotrophic lateral sclerosis. In addition to its portfolio of novel drugs, Biogen also develops and commercializes biosimilars. The company's pipeline is concentrated on potential breakthrough treatments in neurology, immunology, and rare diseases, aiming to address significant unmet medical needs and improve patient outcomes worldwide.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-14 | English | |
| Major Shareholding Notification 2026 | 2026-05-06 | English | |
| Major Shareholding Notification 2026 | 2026-04-29 | English | |
| 10-Q - BIOGEN INC. (0000875045) (Filer) | 2026-04-29 | English | |
| 8-K - BIOGEN INC. (0000875045) (Filer) | 2026-04-29 | English | |
| ARS | 2026-04-28 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46003499 | 8-K | 2026-05-14 | English | ||
| 46147249 | Major Shareholding Notification 2026 | 2026-05-06 | English | ||
| 46147251 | Major Shareholding Notification 2026 | 2026-04-29 | English | ||
| 38512550 | 10-Q - BIOGEN INC. (0000875045) (Filer) | 2026-04-29 | English | ||
| 38494955 | 8-K - BIOGEN INC. (0000875045) (Filer) | 2026-04-29 | English | ||
| 46147256 | ARS | 2026-04-28 | English | ||
| 46147325 | DEFA14A | 2026-04-28 | English | ||
| 46147321 | DEF 14A | 2026-04-28 | English | ||
| 46147329 | Major Shareholding Notification 2026 | 2026-04-07 | English | ||
| 33590958 | 8-K - BIOGEN INC. (0000875045) (Filer) | 2026-04-06 | English | ||
| 33122713 | 8-K - BIOGEN INC. (0000875045) (Filer) | 2026-03-31 | English | ||
| 33052213 | SCHEDULE 13G/A - BIOGEN INC. (0000875045) (Subject) | 2026-03-26 | English | ||
| 46147335 | CURRENT REPORT | 2026-03-11 | English | ||
| 32882744 | 4 - BIOGEN INC. (0000875045) (Filer) | 2026-02-18 | English | ||
| 32882743 | 4 - BIOGEN INC. (0000875045) (Filer) | 2026-02-18 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cipla Ltd.
Global pharmaceutical firm producing generic and branded me…
|
CIPLA | IN | Manufacturing |
|
Cisen Pharmaceutical Co.,Ltd.
Develops and manufactures injections, solid oral forms, API…
|
603367 | CN | Manufacturing |
|
Citi Pharma Ltd.
Manufactures pharmaceuticals, medical chemicals, botanical …
|
CPHL | PK | Manufacturing |
|
CITIUS ONCOLOGY, INC.
Biopharmaceutical company developing and commercializing ta…
|
CTOR | US | Manufacturing |
|
Citius Pharmaceuticals, Inc.
A late-stage biopharmaceutical company developing and comme…
|
CTXR | US | Manufacturing |
|
CKD Bio Corp.
Develops APIs, intermediates, and probiotics using fermenta…
|
063160 | KR | Manufacturing |
|
Claritas Pharmaceuticals, Inc.
Clinical-stage specialty pharma focused on developing thera…
|
CLAZF | CA | Manufacturing |
|
Clearmind Medicine Inc.
Clinical-stage psychedelic pharma firm developing treatment…
|
CMND | CA | Manufacturing |
|
Clearside Biomedical, Inc.
Biopharmaceutical firm with an FDA-approved microinjector f…
|
CLSD | US | Manufacturing |
|
Clene Inc.
A clinical-stage biopharma developing nanotherapeutics for …
|
CLNN | US | Manufacturing |
BIOGEN INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30291/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30291 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30291 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30291 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30291}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BIOGEN INC. (id: 30291)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.